Skip to content

PRCT - PROCEPT BioRobotics Corp - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchP

Procept Biorobotics Corp

PRCT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

P

PRCTProcept Biorobotics Corp

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $42.43
52-wk low: $16.66
Prev close: $29.29
Mkt cap: $1.21B
Beta: 0.89
P/S: 3.6x

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$262.0M

P7
Point72
Steven Cohen · Q1 2026 13F
$28.2M
position
MI
Millennium

Earnings

Reported Aug 4, 2026

Earnings came in 2.2% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -32.5%
Market cap: $1.2B

Valuation

P/S3.60
P/B3.55

Quality

Operating margin-29.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: PRCT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Market cap: $1.21B
Beta: 0.89

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

3.6x

Profit margin

-32.5%

Op margin

-29.0%

ROE

-30.2%

Israel Englander · Q2 2026 13F

$14.1M

position

AQ

AQR

Q2 2026 13F

$8.4M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for PRCT

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.47-2.2%

-$0.46 expected

Next report

What the street expects next

EPS expected

-$0.39

-$0.42 to -$0.34

Revenue expected

$101.1M

13 analysts

Last 30 days

0up7down

Analysts cutting estimates

Estimate drift

0.05

Change in 30 days

-30.2%

ROA-14.4%

Growth

Beta0.89